1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Molecular Imaging System Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-5D10240
Home | Market Reports | Health| Medical Devices & Equipment
Global Nuclear Molecular Imaging System Market Research Report 2022
BUY CHAPTERS

Global Nuclear Molecular Imaging System Market Research Report 2025

Code: QYRE-Auto-5D10240
Report
February 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nuclear Molecular Imaging System Market Size

The global market for Nuclear Molecular Imaging System was valued at US$ 2551 million in the year 2024 and is projected to reach a revised size of US$ 4096 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Nuclear Molecular Imaging System Market

Nuclear Molecular Imaging System Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Molecular Imaging System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Molecular Imaging System.
The Nuclear Molecular Imaging System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Molecular Imaging System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Molecular Imaging System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nuclear Molecular Imaging System Market Report

Report Metric Details
Report Name Nuclear Molecular Imaging System Market
Accounted market size in year US$ 2551 million
Forecasted market size in 2031 US$ 4096 million
CAGR 7.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bruker, GE Healthcare, Siemens Healthcare, Philips Healthcare, Canon Medical Systems, Hitachi Medical, Digirad Corporation, DDD-Diagnostics A/S, Neusoft Medical Systems Co. Ltd., Mediso Medical Imaging Systems, Ltd., SurgicEye GmbH, CMR Naviscan Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nuclear Molecular Imaging System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nuclear Molecular Imaging System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nuclear Molecular Imaging System Market growing?

Ans: The Nuclear Molecular Imaging System Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Nuclear Molecular Imaging System Market size in 2031?

Ans: The Nuclear Molecular Imaging System Market size in 2031 will be US$ 4096 million.

Who are the main players in the Nuclear Molecular Imaging System Market report?

Ans: The main players in the Nuclear Molecular Imaging System Market are Bruker, GE Healthcare, Siemens Healthcare, Philips Healthcare, Canon Medical Systems, Hitachi Medical, Digirad Corporation, DDD-Diagnostics A/S, Neusoft Medical Systems Co. Ltd., Mediso Medical Imaging Systems, Ltd., SurgicEye GmbH, CMR Naviscan Corporation

What are the Application segmentation covered in the Nuclear Molecular Imaging System Market report?

Ans: The Applications covered in the Nuclear Molecular Imaging System Market report are Oncology, Cardiology, Neurology, Others

What are the Type segmentation covered in the Nuclear Molecular Imaging System Market report?

Ans: The Types covered in the Nuclear Molecular Imaging System Market report are Positron Emission Tomography, Single-photon Emission Computed Tomography, Planar Scintigraphy Systems

Recommended Reports

Medical Imaging Systems

Nuclear and Molecular Imaging

Molecular Diagnostics

1 Nuclear Molecular Imaging System Market Overview
1.1 Product Definition
1.2 Nuclear Molecular Imaging System by Type
1.2.1 Global Nuclear Molecular Imaging System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Positron Emission Tomography
1.2.3 Single-photon Emission Computed Tomography
1.2.4 Planar Scintigraphy Systems
1.3 Nuclear Molecular Imaging System by Application
1.3.1 Global Nuclear Molecular Imaging System Market Value by Application (2024 VS 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Global Nuclear Molecular Imaging System Market Size Estimates and Forecasts
1.4.1 Global Nuclear Molecular Imaging System Revenue 2020-2031
1.4.2 Global Nuclear Molecular Imaging System Sales 2020-2031
1.4.3 Global Nuclear Molecular Imaging System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nuclear Molecular Imaging System Market Competition by Manufacturers
2.1 Global Nuclear Molecular Imaging System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nuclear Molecular Imaging System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nuclear Molecular Imaging System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nuclear Molecular Imaging System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nuclear Molecular Imaging System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Molecular Imaging System, Product Type & Application
2.7 Global Key Manufacturers of Nuclear Molecular Imaging System, Date of Enter into This Industry
2.8 Global Nuclear Molecular Imaging System Market Competitive Situation and Trends
2.8.1 Global Nuclear Molecular Imaging System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nuclear Molecular Imaging System Players Market Share by Revenue
2.8.3 Global Nuclear Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nuclear Molecular Imaging System Market Scenario by Region
3.1 Global Nuclear Molecular Imaging System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nuclear Molecular Imaging System Sales by Region: 2020-2031
3.2.1 Global Nuclear Molecular Imaging System Sales by Region: 2020-2025
3.2.2 Global Nuclear Molecular Imaging System Sales by Region: 2026-2031
3.3 Global Nuclear Molecular Imaging System Revenue by Region: 2020-2031
3.3.1 Global Nuclear Molecular Imaging System Revenue by Region: 2020-2025
3.3.2 Global Nuclear Molecular Imaging System Revenue by Region: 2026-2031
3.4 North America Nuclear Molecular Imaging System Market Facts & Figures by Country
3.4.1 North America Nuclear Molecular Imaging System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nuclear Molecular Imaging System Sales by Country (2020-2031)
3.4.3 North America Nuclear Molecular Imaging System Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Molecular Imaging System Market Facts & Figures by Country
3.5.1 Europe Nuclear Molecular Imaging System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nuclear Molecular Imaging System Sales by Country (2020-2031)
3.5.3 Europe Nuclear Molecular Imaging System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Molecular Imaging System Market Facts & Figures by Region
3.6.1 Asia Pacific Nuclear Molecular Imaging System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nuclear Molecular Imaging System Sales by Region (2020-2031)
3.6.3 Asia Pacific Nuclear Molecular Imaging System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nuclear Molecular Imaging System Market Facts & Figures by Country
3.7.1 Latin America Nuclear Molecular Imaging System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nuclear Molecular Imaging System Sales by Country (2020-2031)
3.7.3 Latin America Nuclear Molecular Imaging System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Molecular Imaging System Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Molecular Imaging System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nuclear Molecular Imaging System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nuclear Molecular Imaging System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Molecular Imaging System Sales by Type (2020-2031)
4.1.1 Global Nuclear Molecular Imaging System Sales by Type (2020-2025)
4.1.2 Global Nuclear Molecular Imaging System Sales by Type (2026-2031)
4.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Type (2020-2031)
4.2 Global Nuclear Molecular Imaging System Revenue by Type (2020-2031)
4.2.1 Global Nuclear Molecular Imaging System Revenue by Type (2020-2025)
4.2.2 Global Nuclear Molecular Imaging System Revenue by Type (2026-2031)
4.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Type (2020-2031)
4.3 Global Nuclear Molecular Imaging System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nuclear Molecular Imaging System Sales by Application (2020-2031)
5.1.1 Global Nuclear Molecular Imaging System Sales by Application (2020-2025)
5.1.2 Global Nuclear Molecular Imaging System Sales by Application (2026-2031)
5.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Application (2020-2031)
5.2 Global Nuclear Molecular Imaging System Revenue by Application (2020-2031)
5.2.1 Global Nuclear Molecular Imaging System Revenue by Application (2020-2025)
5.2.2 Global Nuclear Molecular Imaging System Revenue by Application (2026-2031)
5.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Application (2020-2031)
5.3 Global Nuclear Molecular Imaging System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bruker
6.1.1 Bruker Company Information
6.1.2 Bruker Description and Business Overview
6.1.3 Bruker Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bruker Nuclear Molecular Imaging System Product Portfolio
6.1.5 Bruker Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Company Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GE Healthcare Nuclear Molecular Imaging System Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Siemens Healthcare
6.3.1 Siemens Healthcare Company Information
6.3.2 Siemens Healthcare Description and Business Overview
6.3.3 Siemens Healthcare Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Siemens Healthcare Nuclear Molecular Imaging System Product Portfolio
6.3.5 Siemens Healthcare Recent Developments/Updates
6.4 Philips Healthcare
6.4.1 Philips Healthcare Company Information
6.4.2 Philips Healthcare Description and Business Overview
6.4.3 Philips Healthcare Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Philips Healthcare Nuclear Molecular Imaging System Product Portfolio
6.4.5 Philips Healthcare Recent Developments/Updates
6.5 Canon Medical Systems
6.5.1 Canon Medical Systems Company Information
6.5.2 Canon Medical Systems Description and Business Overview
6.5.3 Canon Medical Systems Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Canon Medical Systems Nuclear Molecular Imaging System Product Portfolio
6.5.5 Canon Medical Systems Recent Developments/Updates
6.6 Hitachi Medical
6.6.1 Hitachi Medical Company Information
6.6.2 Hitachi Medical Description and Business Overview
6.6.3 Hitachi Medical Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hitachi Medical Nuclear Molecular Imaging System Product Portfolio
6.6.5 Hitachi Medical Recent Developments/Updates
6.7 Digirad Corporation
6.7.1 Digirad Corporation Company Information
6.7.2 Digirad Corporation Description and Business Overview
6.7.3 Digirad Corporation Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Digirad Corporation Nuclear Molecular Imaging System Product Portfolio
6.7.5 Digirad Corporation Recent Developments/Updates
6.8 DDD-Diagnostics A/S
6.8.1 DDD-Diagnostics A/S Company Information
6.8.2 DDD-Diagnostics A/S Description and Business Overview
6.8.3 DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Portfolio
6.8.5 DDD-Diagnostics A/S Recent Developments/Updates
6.9 Neusoft Medical Systems Co. Ltd.
6.9.1 Neusoft Medical Systems Co. Ltd. Company Information
6.9.2 Neusoft Medical Systems Co. Ltd. Description and Business Overview
6.9.3 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Portfolio
6.9.5 Neusoft Medical Systems Co. Ltd. Recent Developments/Updates
6.10 Mediso Medical Imaging Systems, Ltd.
6.10.1 Mediso Medical Imaging Systems, Ltd. Company Information
6.10.2 Mediso Medical Imaging Systems, Ltd. Description and Business Overview
6.10.3 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Portfolio
6.10.5 Mediso Medical Imaging Systems, Ltd. Recent Developments/Updates
6.11 SurgicEye GmbH
6.11.1 SurgicEye GmbH Company Information
6.11.2 SurgicEye GmbH Description and Business Overview
6.11.3 SurgicEye GmbH Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SurgicEye GmbH Nuclear Molecular Imaging System Product Portfolio
6.11.5 SurgicEye GmbH Recent Developments/Updates
6.12 CMR Naviscan Corporation
6.12.1 CMR Naviscan Corporation Company Information
6.12.2 CMR Naviscan Corporation Description and Business Overview
6.12.3 CMR Naviscan Corporation Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CMR Naviscan Corporation Nuclear Molecular Imaging System Product Portfolio
6.12.5 CMR Naviscan Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Molecular Imaging System Industry Chain Analysis
7.2 Nuclear Molecular Imaging System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Molecular Imaging System Production Mode & Process Analysis
7.4 Nuclear Molecular Imaging System Sales and Marketing
7.4.1 Nuclear Molecular Imaging System Sales Channels
7.4.2 Nuclear Molecular Imaging System Distributors
7.5 Nuclear Molecular Imaging System Customer Analysis
8 Nuclear Molecular Imaging System Market Dynamics
8.1 Nuclear Molecular Imaging System Industry Trends
8.2 Nuclear Molecular Imaging System Market Drivers
8.3 Nuclear Molecular Imaging System Market Challenges
8.4 Nuclear Molecular Imaging System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nuclear Molecular Imaging System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nuclear Molecular Imaging System Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nuclear Molecular Imaging System Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nuclear Molecular Imaging System Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nuclear Molecular Imaging System Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nuclear Molecular Imaging System Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nuclear Molecular Imaging System Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nuclear Molecular Imaging System Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nuclear Molecular Imaging System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nuclear Molecular Imaging System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nuclear Molecular Imaging System, Product Type & Application
 Table 12. Global Key Manufacturers of Nuclear Molecular Imaging System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nuclear Molecular Imaging System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Molecular Imaging System as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nuclear Molecular Imaging System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nuclear Molecular Imaging System Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nuclear Molecular Imaging System Sales Market Share by Region (2020-2025)
 Table 19. Global Nuclear Molecular Imaging System Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nuclear Molecular Imaging System Sales Market Share by Region (2026-2031)
 Table 21. Global Nuclear Molecular Imaging System Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nuclear Molecular Imaging System Revenue Market Share by Region (2020-2025)
 Table 23. Global Nuclear Molecular Imaging System Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nuclear Molecular Imaging System Revenue Market Share by Region (2026-2031)
 Table 25. North America Nuclear Molecular Imaging System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nuclear Molecular Imaging System Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nuclear Molecular Imaging System Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nuclear Molecular Imaging System Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nuclear Molecular Imaging System Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nuclear Molecular Imaging System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nuclear Molecular Imaging System Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nuclear Molecular Imaging System Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nuclear Molecular Imaging System Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nuclear Molecular Imaging System Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nuclear Molecular Imaging System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nuclear Molecular Imaging System Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nuclear Molecular Imaging System Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nuclear Molecular Imaging System Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nuclear Molecular Imaging System Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nuclear Molecular Imaging System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nuclear Molecular Imaging System Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nuclear Molecular Imaging System Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nuclear Molecular Imaging System Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nuclear Molecular Imaging System Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nuclear Molecular Imaging System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nuclear Molecular Imaging System Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nuclear Molecular Imaging System Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nuclear Molecular Imaging System Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nuclear Molecular Imaging System Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nuclear Molecular Imaging System Sales (K Units) by Type (2020-2025)
 Table 51. Global Nuclear Molecular Imaging System Sales (K Units) by Type (2026-2031)
 Table 52. Global Nuclear Molecular Imaging System Sales Market Share by Type (2020-2025)
 Table 53. Global Nuclear Molecular Imaging System Sales Market Share by Type (2026-2031)
 Table 54. Global Nuclear Molecular Imaging System Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nuclear Molecular Imaging System Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nuclear Molecular Imaging System Revenue Market Share by Type (2020-2025)
 Table 57. Global Nuclear Molecular Imaging System Revenue Market Share by Type (2026-2031)
 Table 58. Global Nuclear Molecular Imaging System Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Nuclear Molecular Imaging System Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Nuclear Molecular Imaging System Sales (K Units) by Application (2020-2025)
 Table 61. Global Nuclear Molecular Imaging System Sales (K Units) by Application (2026-2031)
 Table 62. Global Nuclear Molecular Imaging System Sales Market Share by Application (2020-2025)
 Table 63. Global Nuclear Molecular Imaging System Sales Market Share by Application (2026-2031)
 Table 64. Global Nuclear Molecular Imaging System Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nuclear Molecular Imaging System Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nuclear Molecular Imaging System Revenue Market Share by Application (2020-2025)
 Table 67. Global Nuclear Molecular Imaging System Revenue Market Share by Application (2026-2031)
 Table 68. Global Nuclear Molecular Imaging System Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Nuclear Molecular Imaging System Price (US$/Unit) by Application (2026-2031)
 Table 70. Bruker Company Information
 Table 71. Bruker Description and Business Overview
 Table 72. Bruker Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bruker Nuclear Molecular Imaging System Product
 Table 74. Bruker Recent Developments/Updates
 Table 75. GE Healthcare Company Information
 Table 76. GE Healthcare Description and Business Overview
 Table 77. GE Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GE Healthcare Nuclear Molecular Imaging System Product
 Table 79. GE Healthcare Recent Developments/Updates
 Table 80. Siemens Healthcare Company Information
 Table 81. Siemens Healthcare Description and Business Overview
 Table 82. Siemens Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Siemens Healthcare Nuclear Molecular Imaging System Product
 Table 84. Siemens Healthcare Recent Developments/Updates
 Table 85. Philips Healthcare Company Information
 Table 86. Philips Healthcare Description and Business Overview
 Table 87. Philips Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Philips Healthcare Nuclear Molecular Imaging System Product
 Table 89. Philips Healthcare Recent Developments/Updates
 Table 90. Canon Medical Systems Company Information
 Table 91. Canon Medical Systems Description and Business Overview
 Table 92. Canon Medical Systems Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Canon Medical Systems Nuclear Molecular Imaging System Product
 Table 94. Canon Medical Systems Recent Developments/Updates
 Table 95. Hitachi Medical Company Information
 Table 96. Hitachi Medical Description and Business Overview
 Table 97. Hitachi Medical Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hitachi Medical Nuclear Molecular Imaging System Product
 Table 99. Hitachi Medical Recent Developments/Updates
 Table 100. Digirad Corporation Company Information
 Table 101. Digirad Corporation Description and Business Overview
 Table 102. Digirad Corporation Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Digirad Corporation Nuclear Molecular Imaging System Product
 Table 104. Digirad Corporation Recent Developments/Updates
 Table 105. DDD-Diagnostics A/S Company Information
 Table 106. DDD-Diagnostics A/S Description and Business Overview
 Table 107. DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. DDD-Diagnostics A/S Nuclear Molecular Imaging System Product
 Table 109. DDD-Diagnostics A/S Recent Developments/Updates
 Table 110. Neusoft Medical Systems Co. Ltd. Company Information
 Table 111. Neusoft Medical Systems Co. Ltd. Description and Business Overview
 Table 112. Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product
 Table 114. Neusoft Medical Systems Co. Ltd. Recent Developments/Updates
 Table 115. Mediso Medical Imaging Systems, Ltd. Company Information
 Table 116. Mediso Medical Imaging Systems, Ltd. Description and Business Overview
 Table 117. Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product
 Table 119. Mediso Medical Imaging Systems, Ltd. Recent Developments/Updates
 Table 120. SurgicEye GmbH Company Information
 Table 121. SurgicEye GmbH Description and Business Overview
 Table 122. SurgicEye GmbH Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. SurgicEye GmbH Nuclear Molecular Imaging System Product
 Table 124. SurgicEye GmbH Recent Developments/Updates
 Table 125. CMR Naviscan Corporation Company Information
 Table 126. CMR Naviscan Corporation Description and Business Overview
 Table 127. CMR Naviscan Corporation Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. CMR Naviscan Corporation Nuclear Molecular Imaging System Product
 Table 129. CMR Naviscan Corporation Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Nuclear Molecular Imaging System Distributors List
 Table 133. Nuclear Molecular Imaging System Customers List
 Table 134. Nuclear Molecular Imaging System Market Trends
 Table 135. Nuclear Molecular Imaging System Market Drivers
 Table 136. Nuclear Molecular Imaging System Market Challenges
 Table 137. Nuclear Molecular Imaging System Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nuclear Molecular Imaging System
 Figure 2. Global Nuclear Molecular Imaging System Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nuclear Molecular Imaging System Market Share by Type: 2024 & 2031
 Figure 4. Positron Emission Tomography Product Picture
 Figure 5. Single-photon Emission Computed Tomography Product Picture
 Figure 6. Planar Scintigraphy Systems Product Picture
 Figure 7. Global Nuclear Molecular Imaging System Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Nuclear Molecular Imaging System Market Share by Application: 2024 & 2031
 Figure 9. Oncology
 Figure 10. Cardiology
 Figure 11. Neurology
 Figure 12. Others
 Figure 13. Global Nuclear Molecular Imaging System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Nuclear Molecular Imaging System Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Nuclear Molecular Imaging System Sales (2020-2031) & (K Units)
 Figure 16. Global Nuclear Molecular Imaging System Average Price (US$/Unit) & (2020-2031)
 Figure 17. Nuclear Molecular Imaging System Report Years Considered
 Figure 18. Nuclear Molecular Imaging System Sales Share by Manufacturers in 2024
 Figure 19. Global Nuclear Molecular Imaging System Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Nuclear Molecular Imaging System Players: Market Share by Revenue in Nuclear Molecular Imaging System in 2024
 Figure 21. Nuclear Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Nuclear Molecular Imaging System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Nuclear Molecular Imaging System Sales Market Share by Country (2020-2031)
 Figure 24. North America Nuclear Molecular Imaging System Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Nuclear Molecular Imaging System Sales Market Share by Country (2020-2031)
 Figure 28. Europe Nuclear Molecular Imaging System Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Nuclear Molecular Imaging System Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Nuclear Molecular Imaging System Revenue Market Share by Region (2020-2031)
 Figure 36. China Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Nuclear Molecular Imaging System Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Nuclear Molecular Imaging System Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Nuclear Molecular Imaging System Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Nuclear Molecular Imaging System Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Nuclear Molecular Imaging System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Nuclear Molecular Imaging System by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Nuclear Molecular Imaging System by Type (2020-2031)
 Figure 55. Global Nuclear Molecular Imaging System Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Nuclear Molecular Imaging System by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Nuclear Molecular Imaging System by Application (2020-2031)
 Figure 58. Global Nuclear Molecular Imaging System Price (US$/Unit) by Application (2020-2031)
 Figure 59. Nuclear Molecular Imaging System Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart